Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL
7/30/2009 9:50:03 AM
COLUMBUS, Ohio, July 29 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Risperidone Oral Solution, 1mg/mL by the U.S. Food and Drug Administration. The product is available in 30mL bottles for immediate shipment to wholesalers and pharmacies nationwide.
comments powered by